2 results match your criteria: "Cancer Center at Sanford Burnham Prebys Medical Discovery Institute[Affiliation]"
Corrigendum: Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.
Front Pharmacol
December 2024
Cancer Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States.
[This corrects the article DOI: 10.3389/fphar.2022.
View Article and Find Full Text PDFInhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex.
Front Pharmacol
December 2022
Cancer Center at Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, United States.
The translation initiation complex 4F (eIF4F) is a rate-limiting factor in protein synthesis. Alterations in eIF4F activity are linked to several diseases, including cancer and infectious diseases. To this end, coronaviruses require eIF4F complex activity to produce proteins essential for their life cycle.
View Article and Find Full Text PDF